Back to search
FDAFDA · Food and drugs·Recall number D-1426-2012

Erythromycin Topical Solution USP, 2%, 60 mL bottle with applicator, Rx only. E. FOUGERA & CO., A division of Fougera Pharmaceuticals, Inc., Melville, New York 11747, NDC 0168-0215-60, UPC 3 0168-0215-60 0.

Published August 1, 2012 · Recall initiated: June 7, 2012

Summary

FDA records drug Class III recall D-1426-2012, published August 1, 2012 and initiated June 7, 2012. Recalling firm: Fougera Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 444 bottles; Lot: Lot #: 418N, Exp 06/13. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Chemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the product.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fougera Pharmaceuticals, Inc.
Distributor
Nationwide.
Lot
Lot #: 418N, Exp 06/13
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Erythromycin Topical Solution USP, 2%, 60 mL bottle with applicator, Rx only. E. FOUGERA & CO., A division of Fougera Pharmaceuticals, Inc., Melville, New York 11747, NDC 0168-0215-60, UPC 3 0168-0215-60 0. recalled?

Yes. FDA published recall D-1426-2012 on August 1, 2012. Reported hazard: Chemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter